Cure of H. pylori infection for Early Age Patients study

Cure of H. pylori infection for Early Age Patients study - Cure of H. pylori infection for Early Age Patients study(CHEAP study)

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000006949

Enrollment

400

Registered

2011-12-26

Start date

2012-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Helicobacter pylori infection

Interventions

Lansoprazole 30mg+AMPC 750mg+CAM 200mg, twice a day for 7days Lansoprazole 30mg+AMPC 750mg+MNZ 250mg, twice a day for 7days

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Subjects who want to receive a Helicobacter pylori infection test and to take eradication treatment if its result is positive. Patients who give a written informed consent

Exclusion criteria

Exclusion criteria: Past history of allergy for the drugs used in this study. Past history of taking eradication therapy. Past history of gastrectomy. Gastric cancer patients, pregnancy or lactation . Severe renal dysfunction ,Blood disease, Infectious Mononucleosis Patients who are disqualified for the study by their physicians

Design outcomes

Primary

Measure	Time frame
Comparison of the eradication rate of the two regimens,PPI+AMPC+CAM vs PPI+AMPC+MNZ for patients less than 40 year-old.	—

Secondary

Measure	Time frame
To evaluate the safety of the two regimens for patients less than 40 year-old.	—

Countries

Japan

Contacts

Public ContactKatsuhiro Mabe

Hokkaido University Hospital Department of Gastroenterology

kmabe@med.hokudai.ac.jp011-716-1161

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026